CompBrief BY VELARION

Companies 2seventy bio

2seventy bio CEO salary & total pay, FY2023: $9.1M

2seventy bio (TSVT) CEO salary, fiscal 2023: Nick Leschly was paid a salary of $798,532 and $9,084,554 in total compensation. Free brief. Every figure links to the company’s own filing.

2seventy bio no longer files a proxy statement; its last pay data is FY2023.

All products and prices

Nick Leschly's complete compensation dossier

A PDF and a CSV sent to your email: Nick Leschly's pay in every fiscal year 2seventy bio reported it, line by line, with Nick Leschly's equity grants and 2seventy bio's disclosed peer group where the company discloses them. Every row is cited to its filing.

One-time report. No refunds.

See an example →
CEO total pay$9,084,554CEO Nick Leschly · source

CEO pay, last three years

  • $6,078,514FY2022
  • $9,084,554FY2023

CEO total pay was $9,084,554 in fiscal 2023, up from $6,078,514 in fiscal 2022.

FY2023: salary $798,532 · bonus $0 · stock awards $6,729,637 · option awards $1,543,185

Frequently asked questions

Who was the highest-paid executive at 2seventy bio in fiscal 2023?
As disclosed, Nick Leschly (President, Chief Executive Officer) was the highest-paid executive at 2seventy bio in fiscal 2023, with total compensation of $9,084,554.
How much does 2seventy bio spend in total on board compensation for fiscal 2023?
As disclosed, 2seventy bio reported total board compensation of $1,123,978 for fiscal 2023.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

Full detail

Every table from the filing. Open any section.

Summary compensation table
Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Nick Leschly$798,532$0$6,729,637$1,543,185$0$0$13,200$9,084,554
President, Chief Executive Officer
Philip Gregory533,219120,0832,215,712474,8260013,2003,357,040
Chief Scientific Officer
William Baird III518,119116,6851,744,288474,8260073,2002,927,118
Chief Operating Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2023 totalFY2022 totalFY2021 totalΔ FY2022→2023
Nick Leschly$9,084,554$6,078,514—↑ +3,006,040
Philip Gregory3,357,0402,531,347—↑ +825,693
William Baird III2,927,118———

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

Incentive-plan design — the Compensation Discussion & Analysis

Our Compensation Committee reviews and approves the compensation of our executive officers and is primarily responsible for determining the compensation for the named executive officers consistent with our overall executive compensation philosophy. The Committee considers our overall performance against goals, individual executive performance, and internal and external equity as key factors in those decisions.

CEO STI target (% of salary)—
CEO LTI target (% of salary)—
Independent consultantAon
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingfalse
Equity grants and outstanding awards

No plan-based awards are on file for this fiscal year.

Outstanding equity awards at fiscal year-end 2023

ExecutiveAwardExercisableShares unvestedExercise priceMarket value unvested
Philip GregoryOption6,419144114.67—
Philip GregoryOption11,7064,39344.17—
Philip GregoryOption44,65050,35013.41—
Philip GregoryOption—50,00013.2—
Philip GregoryRSU—821—3,506
Philip GregoryRSU—4,025—17,187
Philip GregoryRSU—35,625—152,119
Philip GregoryRSU—25,000—106,750
Philip GregoryRSU—142,857—609,999
Philip GregoryOption2,034—78.44—
Philip GregoryOption8,204—117.4—
Nick LeschlyOption20,872459114.67—
Nick LeschlyOption42,24815,70944.17—
Nick LeschlyOption125,490141,51013.41—
Nick LeschlyOption—162,50013.2—
Nick LeschlyRSU—2,667—11,388
Nick LeschlyRSU—5,797—24,753
Nick LeschlyRSU—100,125—427,534
Nick LeschlyRSU—81,250—346,938
Nick LeschlyRSU—428,571—1,829,998
Nick LeschlyOption54,149—38—
Nick LeschlyOption29,535—78.44—
Nick LeschlyOption36,099—117.4—
William Baird IIIOption6,419144114.67—
William Baird IIIOption11,7064,39244.17—
William Baird IIIOption31,72535,77513.41—
William Baird IIIOption—50,00013.2—
William Baird IIIRSU—821—3,506
William Baird IIIRSU—4,025—17,187
William Baird IIIRSU—25,312—108,082
William Baird IIIRSU—25,000—106,750
William Baird IIIRSU—107,143—457,501
Director compensation
DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Wei Lin, M.D., Ph.DIndependent · Nominating and Corporate Governance$61,250$230,708$330,090——$622,048
Daniel S. LynchIndependent · Audit · Compensation (Chair) · Not standing for re-election104,00099,204133,298——336,502
Denice TorresIndependent · Lead Independent Director · Audit · Compensation · Nominating and Corporate Governance (Chair)71,50099,204133,298——304,002
Sarah GlickmanIndependent · Audit (Chair) · Compensation70,50099,204133,298——303,002
Marcela Maus, M.D., Ph.DIndependent · Nominating and Corporate Governance57,50099,204133,298——290,002
Ramy Ibrahim, M.DIndependent · Departed during FY32,50099,204132,360——264,064

Board fee structure and ownership guideline

Annual cash retainer$45,000
Annual equity retainer—
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)18,000 / 15,000 / 10,000
Stock ownership guideline—

Total cost of the board

ComponentFY2023
Cash retainers and fees$397,250
Equity awards (grant-date value)$726,728
All other compensation$0
Total cost of the board$1,123,978

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

Peer group, and who names 2seventy bio as a peer

Companies that benchmark against TSVT

2 companies name TSVT as a compensation peer

Each company listed discloses TSVT in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named TSVT in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
12seventy bio2023Nick Leschly$798,532$6,729,637$1,543,185$0$9,084,554

Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

Say-on-pay history and pay ratio
Meeting yearMeeting dateForAgainstAbstainSupportOutcome
2024——————

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.

Say-on-pay — history, company’s computation

Meeting yearMeeting dateApproval — company’s computation
2024——a

a. Voting standard not stated in the filing.

Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

Insider trades since the proxy

Every insider equity transaction reported on Form 4 after the 2023 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Jessica SnowSee Remarks2024-05-03D15$5$74CommonForm 4 ↗
Jessica SnowSee Remarks2024-06-03D64942,714CommonForm 4 ↗
Victoria EatwellChief Financial Officer2024-06-03D1,16744,881CommonForm 4 ↗
Casdin Capital, LLCDirector2024-06-10A12,050447,357Derivative, Class A CommonForm 4 ↗
Casdin Capital, LLCDirector2024-06-10A6,025——CommonForm 4 ↗
Charles W. NewtonDirector2024-06-10A12,05000Derivative, Class A CommonForm 4 ↗
Charles W. NewtonDirector2024-06-10A6,02500CommonForm 4 ↗
Denice TorresDirector2024-06-10A24,10000Derivative, Class A CommonForm 4 ↗
Denice TorresDirector2024-06-10A12,05000CommonForm 4 ↗
Sarah GlickmanDirector2024-06-10A24,10000Derivative, Class A CommonForm 4 ↗
Sarah GlickmanDirector2024-06-10A12,05000CommonForm 4 ↗
Lin WeiDirector2024-06-10A24,10000Derivative, Class A CommonForm 4 ↗
Lin WeiDirector2024-06-10A12,05000CommonForm 4 ↗
Marcela Maus V.Director2024-06-10A24,10000Derivative, Class A CommonForm 4 ↗
Marcela Maus V.Director2024-06-10A12,05000CommonForm 4 ↗
Victoria EatwellChief Financial Officer2024-07-01A245,86400CommonForm 4 ↗
Jessica SnowSee Remarks2024-07-01A108,53800CommonForm 4 ↗
William Baird IIIDirector2024-07-01A586,02200CommonForm 4 ↗
Victoria EatwellChief Financial Officer2024-07-02D12448CommonForm 4 ↗
Jessica SnowSee Remarks2024-07-02D14456CommonForm 4 ↗
Victoria EatwellChief Financial Officer2024-08-05D13452CommonForm 4 ↗
Jessica SnowSee Remarks2024-08-14D7,816433,760CommonForm 4 ↗
Victoria EatwellChief Financial Officer2024-10-03D1,23055,718CommonForm 4 ↗
Jessica SnowSee Remarks2024-10-03D67953,157CommonForm 4 ↗
Marcela Maus V.Director2024-11-18D3,900313,182CommonForm 4 ↗
Jessica SnowSee Remarks2024-12-13D2,28737,393CommonForm 4 ↗
William Baird IIIDirector2025-01-03D31,718393,121CommonForm 4 ↗
Victoria EatwellChief Financial Officer2025-01-03D1,01332,974CommonForm 4 ↗
Nick LeschlyDirector2025-01-03D85,9783252,423CommonForm 4 ↗
Jessica SnowSee Remarks2025-01-03D1,00032,936CommonForm 4 ↗
William Baird IIIDirector2025-01-06A176,00000Derivative, Class A CommonForm 4 ↗
William Baird IIIDirector2025-01-06A264,00000CommonForm 4 ↗
Victoria EatwellChief Financial Officer2025-01-06A72,00000Derivative, Class A CommonForm 4 ↗
Victoria EatwellChief Financial Officer2025-01-06A108,00000CommonForm 4 ↗
Jessica SnowSee Remarks2025-01-06A70,75000Derivative, Class A CommonForm 4 ↗
Jessica SnowSee Remarks2025-01-06A106,15000CommonForm 4 ↗
William Baird IIIDirector2025-01-06D76332,120CommonForm 4 ↗
Victoria EatwellChief Financial Officer2025-01-06D973270CommonForm 4 ↗
Nick LeschlyDirector2025-01-06D89232,478CommonForm 4 ↗
Jessica SnowSee Remarks2025-01-06D5,000313,972CommonForm 4 ↗
Jessica SnowSee Remarks2025-01-06D1143317CommonForm 4 ↗
Jessica SnowSee Remarks2025-01-06D1,83835,136CommonForm 4 ↗
Jessica SnowSee Remarks2025-01-07D1863491CommonForm 4 ↗
Kynam Global Healthcare Master Fund, LPGreater-than-10% holder2025-03-11D5,142,111525,350,607CommonForm 4 ↗
Kynam Global Healthcare Master Fund, LPGreater-than-10% holder2025-03-11D5,142,111525,350,607CommonForm 4 ↗
Kynam Global Healthcare Master Fund, LPGreater-than-10% holder2025-03-11D5,953,825529,352,357CommonForm 4 ↗
Victoria EatwellChief Financial Officer2025-03-17D2,592512,817CommonForm 4 ↗
William Baird IIIDirector2025-03-17D5,092525,180CommonForm 4 ↗
Jessica SnowChief Operating Officer2025-03-17D2,298511,364CommonForm 4 ↗
William Baird IIIDirector2025-05-13D176,000——Derivative, Class A CommonForm 4 ↗
William Baird IIIDirector2025-05-13D182,000——Derivative, Class A CommonForm 4 ↗
William Baird IIIDirector2025-05-13D118,209——CommonForm 4 ↗
William Baird IIIDirector2025-05-13D1,002,825——CommonForm 4 ↗
Denice TorresDirector2025-05-13D24,100——Derivative, Class A CommonForm 4 ↗
Denice TorresDirector2025-05-13D19,510——CommonForm 4 ↗
Denice TorresDirector2025-05-13D12,050——CommonForm 4 ↗
Charles W. NewtonDirector2025-05-13D12,050——Derivative, Class A CommonForm 4 ↗
Charles W. NewtonDirector2025-05-13D33,400——Derivative, Class A CommonForm 4 ↗
Charles W. NewtonDirector2025-05-13D5,533——CommonForm 4 ↗
Charles W. NewtonDirector2025-05-13D17,092——CommonForm 4 ↗
Marcela Maus V.Director2025-05-13D24,100——Derivative, Class A CommonForm 4 ↗
Marcela Maus V.Director2025-05-13D11,702——CommonForm 4 ↗
Marcela Maus V.Director2025-05-13D12,050——CommonForm 4 ↗
Lin WeiDirector2025-05-13D24,100——Derivative, Class A CommonForm 4 ↗
Lin WeiDirector2025-05-13D15,267——CommonForm 4 ↗
Lin WeiDirector2025-05-13D17,583——CommonForm 4 ↗
Jessica SnowChief Operating Officer2025-05-13D70,750——Derivative, Class A CommonForm 4 ↗
Jessica SnowChief Operating Officer2025-05-13D18,300——Derivative, Class A CommonForm 4 ↗
Jessica SnowChief Operating Officer2025-05-13D11,064——CommonForm 4 ↗
Jessica SnowChief Operating Officer2025-05-13D247,230——CommonForm 4 ↗
Victoria EatwellChief Financial Officer2025-05-13D72,000——Derivative, Class A CommonForm 4 ↗
Victoria EatwellChief Financial Officer2025-05-13D18,300——Derivative, Class A CommonForm 4 ↗
Victoria EatwellChief Financial Officer2025-05-13D21,700——Derivative, Class A CommonForm 4 ↗
Victoria EatwellChief Financial Officer2025-05-13D43,276——CommonForm 4 ↗
Victoria EatwellChief Financial Officer2025-05-13D401,111——CommonForm 4 ↗
Nick LeschlyDirector2025-05-13D469,000——Derivative, Class A CommonForm 4 ↗
Nick LeschlyDirector2025-05-13D41,000——CommonForm 4 ↗
Nick LeschlyDirector2025-05-13D15,233——CommonForm 4 ↗
Nick LeschlyDirector2025-05-13D897,642——CommonForm 4 ↗
Nick LeschlyDirector2025-05-13D335,964——CommonForm 4 ↗
Casdin Capital, LLCDirector2025-05-13D33,400——Derivative, Class A CommonForm 4 ↗
Casdin Capital, LLCDirector2025-05-13D12,050——Derivative, Class A CommonForm 4 ↗
Casdin Capital, LLCDirector2025-05-13D2,000,000510,000,000CommonForm 4 ↗
Casdin Capital, LLCDirector2025-05-13D22,6255113,125CommonForm 4 ↗
Sarah GlickmanDirector2025-05-13D24,100——Derivative, Class A CommonForm 4 ↗
Sarah GlickmanDirector2025-05-13D15,602——CommonForm 4 ↗
Sarah GlickmanDirector2025-05-13D12,050——CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

Sources (100 citations)

Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.

  • Section 01, Nick Leschly. DEF 14A, filed 2024-04-25. Section “Executive Compensation” · page 16. As printed: 9,084,554. View filing ↗
  • Section 01, Philip Gregory. DEF 14A, filed 2024-04-25. Section “Executive Compensation” · page 16. As printed: 3,357,040. View filing ↗
  • Section 01, William Baird III. DEF 14A, filed 2024-04-25. Section “Executive Compensation” · page 16. As printed: 2,927,118. View filing ↗
  • Section 08, Wei Lin, M.D., Ph.D. DEF 14A, filed 2024-04-25. Section “Director Compensation”. As printed: 622,048. View filing ↗
  • Section 08, Daniel S. Lynch. DEF 14A, filed 2024-04-25. Section “Director Compensation”. As printed: 336,502. View filing ↗
  • Section 08, Denice Torres. DEF 14A, filed 2024-04-25. Section “Director Compensation”. As printed: 304,002. View filing ↗
  • Section 08, Sarah Glickman. DEF 14A, filed 2024-04-25. Section “Director Compensation”. As printed: 303,002. View filing ↗
  • Section 08, Marcela Maus, M.D., Ph.D. DEF 14A, filed 2024-04-25. Section “Director Compensation”. As printed: 290,002. View filing ↗
  • Section 08, Ramy Ibrahim, M.D. DEF 14A, filed 2024-04-25. Section “Director Compensation”. As printed: 264,064. View filing ↗
  • Section 02, Jessica Snow 2024-05-03. Form 4, filed 2024-05-16. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2024-06-03. Form 4, filed 2024-06-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Victoria Eatwell 2024-06-03. Form 4, filed 2024-06-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Casdin Capital, LLC 2024-06-10. Form 4, filed 2024-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Casdin Capital, LLC 2024-06-10. Form 4, filed 2024-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Charles W. Newton 2024-06-10. Form 4, filed 2024-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Charles W. Newton 2024-06-10. Form 4, filed 2024-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Denice Torres 2024-06-10. Form 4, filed 2024-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Denice Torres 2024-06-10. Form 4, filed 2024-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Sarah Glickman 2024-06-10. Form 4, filed 2024-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Sarah Glickman 2024-06-10. Form 4, filed 2024-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Lin Wei 2024-06-10. Form 4, filed 2024-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Lin Wei 2024-06-10. Form 4, filed 2024-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Marcela Maus V. 2024-06-10. Form 4, filed 2024-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Marcela Maus V. 2024-06-10. Form 4, filed 2024-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Victoria Eatwell 2024-07-01. Form 4, filed 2024-07-03. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2024-07-01. Form 4, filed 2024-07-03. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, William Baird III 2024-07-01. Form 4, filed 2024-07-03. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Victoria Eatwell 2024-07-02. Form 4, filed 2024-07-03. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2024-07-02. Form 4, filed 2024-07-03. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Victoria Eatwell 2024-08-05. Form 4, filed 2024-08-07. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2024-08-14. Form 4, filed 2024-08-16. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Victoria Eatwell 2024-10-03. Form 4, filed 2024-10-07. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2024-10-03. Form 4, filed 2024-10-07. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Marcela Maus V. 2024-11-18. Form 4, filed 2024-11-20. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2024-12-13. Form 4, filed 2024-12-17. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, William Baird III 2025-01-03. Form 4, filed 2025-01-07. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Victoria Eatwell 2025-01-03. Form 4, filed 2025-01-07. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Nick Leschly 2025-01-03. Form 4, filed 2025-01-07. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2025-01-03. Form 4, filed 2025-01-07. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, William Baird III 2025-01-06. Form 4, filed 2025-01-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, William Baird III 2025-01-06. Form 4, filed 2025-01-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Victoria Eatwell 2025-01-06. Form 4, filed 2025-01-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Victoria Eatwell 2025-01-06. Form 4, filed 2025-01-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2025-01-06. Form 4, filed 2025-01-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2025-01-06. Form 4, filed 2025-01-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, William Baird III 2025-01-06. Form 4, filed 2025-01-07. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Victoria Eatwell 2025-01-06. Form 4, filed 2025-01-07. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Nick Leschly 2025-01-06. Form 4, filed 2025-01-07. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2025-01-06. Form 4, filed 2025-01-07. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2025-01-06. Form 4, filed 2025-01-07. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2025-01-06. Form 4, filed 2025-01-22. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2025-01-07. Form 4, filed 2025-01-07. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Kynam Global Healthcare Master Fund, LP 2025-03-11. Form 4, filed 2025-03-13. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Kynam Global Healthcare Master Fund, LP 2025-03-11. Form 4, filed 2025-03-13. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Kynam Global Healthcare Master Fund, LP 2025-03-11. Form 4, filed 2025-03-13. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Victoria Eatwell 2025-03-17. Form 4, filed 2025-03-19. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, William Baird III 2025-03-17. Form 4, filed 2025-03-19. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2025-03-17. Form 4, filed 2025-03-19. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, William Baird III 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, William Baird III 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, William Baird III 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, William Baird III 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Denice Torres 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Denice Torres 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Denice Torres 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Charles W. Newton 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Charles W. Newton 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Charles W. Newton 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Charles W. Newton 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Marcela Maus V. 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Marcela Maus V. 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Marcela Maus V. 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Lin Wei 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Lin Wei 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Lin Wei 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jessica Snow 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Victoria Eatwell 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Victoria Eatwell 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Victoria Eatwell 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Victoria Eatwell 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Victoria Eatwell 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Nick Leschly 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Nick Leschly 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Nick Leschly 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Nick Leschly 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Nick Leschly 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Casdin Capital, LLC 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Casdin Capital, LLC 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Casdin Capital, LLC 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Casdin Capital, LLC 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Sarah Glickman 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Sarah Glickman 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Sarah Glickman 2025-05-13. Form 4, filed 2025-05-15. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 06, 2024 vote. Form 8-K, filed 2024-03-07. Item 5.07 · say-on-pay result. As reported: —. View filing ↗
  • Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
  • Section 09b board cost (computed). Computed. Cash 397,250 + equity 726,728 + all other 0 = 1,123,978, summed across the director compensation table rows.
  • 2seventy bio (subject), Section 10b CEO total. DEF 14A, filed 2024-04-25. CEO total compensation as printed in 2seventy bio's own proxy. As printed: 9,084,554. View filing ↗